항혈소판제의 선택을 위하여 고려할 점

참고문헌 (26)

1. Antithrombotic Trialist’s Collaboration, "Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.", BMJ, (324), pp.71~86 (2002)
2. Wolf PA, "Probability of stroke: a risk profile from the Framingham study", Stroke, (22), pp.312~318 (1991)
3. Sever PS, "Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).", Diabetes Care, (28), pp.1151~1157 (2005)
4. Atrial Fibrillation Investigators, "Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation, analysis of pooled data from five randomized controlled trials.", Arch Intern Med, (154), pp.1449~1457 (1994)
5. Stroke Prevention in Arial Fibrillation Investigators, "Adjusted- dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial.", Lancet, (348), pp.633~638 (1996)
6. Weinberger J, "Adverse effects and drug interactions of antithrombotic agents used in prevention of ischemic stroke", Drugs, (65), pp.461~471 (2005)
7. Adams HA, "uideline for the early management of patients with ischemic stroke. 2005 Guidelines Update. A scientific statement from the stroke council of the American Heart Association", American Stroke Association., 2005, pp.(36), 916~923
8. Matias-Guiu J, "omparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction. The TACIP study: a randomized, double blinded, multicenter trial.", Stroke, (34), pp.840~848 (2003)
9. Diener HC, "European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke", J Neurol Sci, (143), pp.1~13 (1996)
10. Kwon SU, "Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis. The multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis.", Stroke, (36), pp.782~786 (2005)
11. Mehta SR, "Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.", Lancet, (358), pp.527~533 (2001)
12. Tran H, "Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral artery disease.", JAMA, (292), pp.1867~1874 (2004)
13. Sacco M, "Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.", Diabetes Care, (26), pp.264~272 (2003)
14. raunwald E, "ACC", AHA guideline update for the management of patients with unstable angina and non-ST- segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology, Circulation, pp.2002, (106)[DOI]
15. Clagett GP, "Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.", Chest, (126), pp.S609~S626 (2004)
16. Borja J, "Oral antiplatelet therapy", JAMA, (293), pp.793~ (2005)
17. Gotoh F, "Cilostazol stroke prevention study: a placebo-controlled double-blinded trial for secondary prevention of cerebral ischemia", J Stroke Cerebrovasc Dis, (9), pp.147~157 (2000)
18. CAPRIE Steering Committee, "A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).", Lancet, pp.1329~1339 (1996)
19. Goldstein JL, "Ulcer recurrence in high-risk receiveing nonsteriodal anti-inflammatory drugs plus low-dose aspirin: results of a post hoc sub analysis.", Clin Ther, (26), pp.1637~1643 (2004)
20. Chan FKL, "Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.", N Engl J Med, (35), pp.238~244 (2005)
21. Agrawal NM, "Superiority of lansoprazole vs ranitidine in healing nonsteriodal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-associated gastric ulcer study group.", Arch Intern Med, (160), pp.1455~1461 (2000)
22. Physicians’ desk references, "5th ed. Montvale: Medical economics", pp.2404~2406 (2001), Pletal
23. Diener HC, "Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial.", Lancet, (364), pp.331~337 (2004)
24. Hankey GJ, "Adding aspirin to clopidogrel after TIA and ischemic stroke. Benefits do not match risks.", Neurology, (64), pp.1117~1121 (2006)
25. Poulsen TS, "A critical appraisal of the phenomenon of aspirin resistance.", Cardiology, (104), pp.83~91 (2005)
26. Steinhubl SR, "Resistance to antiplatelet resistance.", J Am Coll Cardiol, (45), pp.1757~1758 (2005)

관련 논문AI추천